Kalgoorlie Gold launches major exploration blitz at Pinjin Project
Kalgoorlie Gold Mining (ASX:KAL) is set to launch its most extensive exploration initiative to date at the Pinjin Gold Project.
Kalgoorlie Gold Mining (ASX:KAL) is set to launch its most extensive exploration initiative to date at the Pinjin Gold Project.
Senator Matt Canavan has been elected leader of the National Party, following the shock resignation of David Littleproud.
Patrys (ASX:PAB) has commenced key manufacturing and regulatory activities for RLS-2201, a proprietary injectable formulation of Quetiapine.
Vandana Hari, Founder of Vanda Insights, discusses her outlook on the oil markets following a report saying the International Energy Agency is proposing the largest release of reserves in history to tackle elevated prices. She speaks with Haidi Stroud-Watts and Avril Hong on Bloomberg: The Asia Trade.
Brian McNamara, CEO at consumer health company Haleon, discusses the company's business strategy as it sees China and growth markets like India as key priorities to expand its product portfolio. He speaks with Haidi Stroud-Watts and Avril Hong on Bloomberg: The Asia Trade.
EV Resources (ASX:EVR) has acquired the remaining 50% interest in Minera Montserrat SAC.
Sean Darby of Mizuho Securities says the markets "were perhaps too benign over the whole inflation story" but now investors will "experience that inflation shock much, much quicker" due to the Middle East conflict.
Energy markets are fluctuating as investors interpret shifting comments from the Trump administration regarding the war in Iran. Bloomberg's Derek Wallbank and Mia Gindis break down the situation.
Alchemy Resources (ASX:ALY) has entered into a binding agreement to sell its Karonie and Lake Rebecca Projects to Forrestania Resources (ASX:FRS).
GQG Partners (ASX:GQG) has reported a 4.3% increase in funds under management for February.
Dateline Resources (ASX:DTR) announced an expansion of its district-scale Music Valley Heavy Rare Earth Project in California.
Rhythm Biosciences (ASX:RHY) achieves its first clinical sale of ColoSTAT, marking its transition to a commercial medical diagnostics company ready for large-scale expansion.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade